Clinical Trials

Find a Clinical Trial

2 Clinical Trials

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

This is a Phase II/III, open-label, single-arm, multicenter study of intravesical BCG plus N-803 in patients with BCG unresponsive high grade non-muscle invasive bladder cancer (NMIBC). All patients treated in the study will receive via a urinary catheter in the...

Interventional / Not Recruiting / NCT03022825

Clinical Trial Details

INSTILADRIN® in Patients With Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Previous multi-dose Phase I and Phase II clinical studies have demonstrated that INSTILADRIN (nadofaragene firadenovec) is a safe and effective treatment for BCG-refractory and recurrent NMIBC. This Phase III study is designed to expand those observations using a high dose...

Interventional / Not Recruiting / NCT02773849

Clinical Trial Details

Commonly Searched Clinical Trials

View All Clinical Trials
Breast Cancer
CAR T-Cell Therapy
Cardiology (Heart Care)
Diabetes
Gastroenterology
Leukemia
Neurosciences
Pediatric Hematology & Oncology (Pediatric Cancer)
Prostate Cancer

Please note that acceptance into any study is dependent on full clinical evaluation as well as details of study status, both of which can only be fully evaluated at the time of a formal visit and screening.